In vivo development of carbapenem resistance in clinical isolates of Enterobacter aerogenes producing multiple β-lactamases

International Journal of Antimicrobial Agents

Volumn 32, Issue 4, 2008, Pages 302-307

  Chen, Ya Gang ^a   Zhang, Ying ^a   Yu, Yun Song ^a   Qu, Ting Ting ^a   Wei, Ze Qing ^a   Shen, Ping ^a   Li, Lan Juan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Antimicrobial resistance mechanisms; Carbapenem; Enterobacter aerogenes; Insertional inactivation; Outer membrane protein

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE CTX M 14; BETA LACTAMASE CTX M 3; BETA LACTAMASE DHA 1; BETA LACTAMASE SHV 5; BETA LACTAMASE TEM 1; CARBAPENEM; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; MINOCYCLINE; OUTER MEMBRANE PROTEIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; PROTEIN OMPE36; SULPERAZON; TIGECYCLINE; TIMENTIN; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CASE REPORT; ENTEROBACTER AEROGENES; ENTEROBACTER INFECTION; GENE; GENE INSERTION SEQUENCE; HOMOLOGOUS RECOMBINATION; HUMAN; IN VIVO STUDY; ISOELECTRIC FOCUSING; KANAMYCIN RESISTANCE GENE; LIVER TRANSPLANTATION; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSED FIELD GEL ELECTROPHORESIS; WESTERN BLOTTING;

ADULT; AMINO ACID SEQUENCE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE INFECTIONS; FATAL OUTCOME; HUMANS; IMIPENEM; LIVER TRANSPLANTATION; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; THIENAMYCINS;

EID: 50549084982     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.02.014     Document Type: Article

References (33)

1. Allerberger F., Koeuth T., Lass F.C., Dierich M.P., Putensen C., Scmutzhard E., et al. Epidemiology of infections due to multiresistant Enterobacter aerogenes in a university hospital. Eur J Clin Microbiol Infect Dis 15 (1996) 517-521
2. Bornet C., Davin-Regli A., Bosi C., Pages J.M., and Bollet C. Imipenem resistance of Enterobacter aerogenes mediated by outer membrane permeability. J Clin Microbiol 38 (2000) 1048-1052
3. De Gheldre Y., Maes N., Rost F., De Ryck R., Clevenbergh P., Vincent J.L., et al. Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance. J Clin Microbiol 35 (1997) 152-160
4. Arpin C., Dubois V., Coulange L., Andre C., Fischer I., Noury P., et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob Agents Chemother 47 (2003) 3506-3514
5. Galdbart J.O., Lemann F., Ainouz D., Feron P., Lambert-Zechovsky N., and Branger C. TEM-24 extended-spectrum beta-lactamase-producing Enterobacter aerogenes: long-term clonal dissemination in French hospitals. Clin Microbiol Infect 6 (2000) 316-323
6. De Gheldre Y., Struelens M.J., Glupczynski Y., De Mol P., Maes N., Nonhoff C., et al. National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998. J Clin Microbiol 39 (2001) 889-896
7. Salso S., Culebras E., Andrade R., and Picazo J.J. Outbreak of TEM-24-producing Enterobacter aerogenes in a Spanish hospital. Microb Drug Resist 9 (2003) 299-305
8. Mammeri H., Laurans G., Eveillard M., Castelain S., and Eb F. Coexistence of SHV-4- and TEM-24-producing Enterobacter aerogenes strains before a large outbreak of TEM-24-producing strains in a French hospital. J Clin Microbiol 39 (2001) 2184-2190
9. Bornet C., Chollet R., Mallea M., Chevalier J., Davin-Regli A., Pages J.M., et al. Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes. Biochem Biophys Res Commun 301 (2003) 985-990
10. Thiolas A., Bornet C., Davin-Regli A., Pages J.M., and Bollet C. Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes. Biochem Biophys Res Commun 317 (2004) 851-856
11. Yigit H., Anderson G.J., Biddle J.W., Steward C.D., Rasheed J.K., Valera L.L., et al. Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs. Antimicrob Agents Chemother 46 (2002) 3817-3822
12. Lavigne J.P., Bouziges N., Chanal C., Mahamat A., Michaux-Charachon S., and Sotto A. Molecular epidemiology of Enterobacteriaceae isolates producing extended-spectrum beta-lactamases in a French hospital. J Clin Microbiol 42 (2004) 3805-3808
13. Danel F., Hall L.M., Gur D., Akalin H.E., and Livermore D.M. Transferable production of PER-1 beta-lactamase in Pseudomonas aeruginosa. J Antimicrob Chemother 35 (1995) 281-294
14. Wei Z.Q., Chen Y.G., Yu Y.S., Lu W.X., and Li L.J. Nosocomial spread of multi-resistant Klebsiella pneumoniae containing a plasmid encoding multiple beta-lactamases. J Med Microbiol 54 (2005) 885-888
15. ACT-1 beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE. Antimicrob Agents Chemother 50 (2006) 3396-3406
16. Mallea M., Chevalier J., Bornet C., Eyraud A., Davin-Regli A., Bollet C., et al. Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology 144 (1998) 3003-3009
17. Charrel R.N., and Pages J.M. De Micco P, Mallea M. Prevalence of outer membrane porin alteration in beta-lactam-antibiotic-resistant Enterobacter aerogenes. Antimicrob Agents Chemother 40 (1996) 2854-2858
18. Walsh T.R., Bolmstrom A., Qwarnstrom A., and Gales A. Evaluation of a new Etest for detecting metallo-beta-lactamases in routine clinical testing. J Clin Microbiol 40 (2002) 2755-2759
19. Elliott E., Brink A.J., van Greune J., Els Z., Woodford N., Turton J., et al. In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase. Clin Infect Dis 42 (2006) e95-e98
20. Piagnerelli M., Kennes B., Brogniez Y., Deplano A., and Govaerts D. Outbreak of nosocomial multidrug-resistant Enterobacter aerogenes in a geriatric unit: failure of isolation contact, analysis of risk factors, and use of pulsed-field gel electrophoresis. Infect Control Hosp Epidemiol 21 (2000) 651-653
21. Dumarche P., De Champs C., Sirot D., Chanal C., Bonnet R., and Sirot J. TEM derivative-producing Enterobacter aerogenes strains: dissemination of a prevalent clone. Antimicrob Agents Chemother 46 (2002) 1128-1131
22. Marchandin H., Godreuil S., Darbas H., Jean-Pierre H., Jumas-Bilak E., Chanal C., et al. Extended-spectrum beta-lactamase TEM-24 in an Aeromonas clinical strain: acquisition from the prevalent Enterobacter aerogenes clone in France. Antimicrob Agents Chemother 47 (2003) 3994-3995
23. Lee J.H., Jung H.I., Jung J.H., Park J.S., Ahn J.B., Jeong S.H., et al. Dissemination of transferable AmpC-type beta-lactamase (CMY-10) in a Korean hospital. Microb Drug Resist 10 (2004) 224-230
24. Fisher J.F., Meroueh S.O., and Mobashery S. Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity. Chem Rev 105 (2005) 395-424
25. Gootz T.D. Global dissemination of beta-lactamases mediating resistance to cephalosporins and carbapenems. Expert Rev Anti Infect Ther 2 (2004) 317-327
26. Nordmann P., and Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 8 (2002) 321-331
27. Bratu S., Landman D., Alam M., Tolentino E., and Quale J. Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York. Antimicrob Agents Chemother 49 (2005) 776-778
28. Shibata N., Doi Y., Yamane K., Yagi T., Kurokawa H., Shibayama K., et al. PCR typing of genetic determinants for metallo-beta-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J Clin Microbiol 41 (2003) 5407-5413
29. Thiolas A., Bollet C., La Scola B., Raoult D., and Pages J.M. Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient. Antimicrob Agents Chemother 49 (2005) 1354-1358
30. Fernandez-Cuenca F., Rodriguez-Martinez J.M., Martinez-Martinez L., and Pascual A. In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC beta-lactamase. Int J Antimicrob Agents 27 (2006) 549-552
31. Dupont M., De E., Chollet R., Chevalier J., and Pages J.M. Enterobacter aerogenes OmpX, a cation-selective channel mar- and osmo-regulated. FEBS Lett 569 (2004) 27-30
32. Hernandez-Alles S., Benedi V.J., Martinez-Martinez L., Pascual A., Aguilar A., Tomas J.M., et al. Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes. Antimicrob Agents Chemother 43 (1999) 937-939
33. DHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases. J Antimicrob Chemother 60 (2007) 410-413